相关实验视频
Updated: Jan 11, 2026

06:48
Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil
Published on: July 29, 2020
5.0K
西班牙儿童肥胖:从2000年到2019年 - - 两项全国代表性研究的比较
Santiago Felipe Gómez1,2,3,4, Paula Berruezo5,6, Silvia Torres5,7
1Gasol Foundation Europe, Sant Boi de Llobregat, Barcelona, Spain, sgomez@gasolfoundation.org.
Obesity facts
|November 14, 2025
概括
在西班牙,儿童肥胖率在过去二十年中显著增加,在女孩和较低社会经济群体中观察到更高的肥胖率和腹部肥胖率. 迫切需要制定卫生政策来解决这个日益严重的儿科健康问题.
科学领域:
- 公共卫生 公共卫生
- 儿科 儿科 儿科
- 流行病学 流行病学
背景情况:
- 对儿童肥胖的全国监测对于制定有效的卫生政策至关重要.
- 这项研究检查了西班牙儿童体重状况的二十年的世俗趋势.
研究的目的:
- 分析1998-2000年至2019-2020年期间西班牙儿科体重状况 (包括超重,肥胖和腹部肥胖) 的变化.
- 根据发展阶段,性别和社会经济因素分层识别趋势.
主要方法:
- 两项全国性横截面研究的比较分析:EnKid (1998-2000年) 和PASOS (2019-2020年).
- 估计健康体重,超重,肥胖,超重,严重肥胖和腹部肥胖的患病率.
- 根据发育阶段,性别和母亲的教育水平进行分层分析.
主要成果:
- 在2000年至2019年期间,腹部肥胖的患病率从16.0%大幅上升至22.6%.
- 在女孩中,肥胖患病率显著增加,从3.16%增加到7.20%.
- 后勤回归显示,与2000年相比,2019年超重,肥胖和腹部肥胖的几率较高,女孩和较低社会经济地位的参与者特别高风险.
结论:
- 在过去的二十年里,西班牙观察到儿童肥胖症的显著增加.
- 迫切需要实施有效的公共卫生政策,以应对儿童肥胖的上升趋势.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163

